Document is current
Any future updates will be listed below
-
Authors
Jiang, Nan
Li, Guangya
Luo, Sen
Kong, Xi
Yin, Shigang
Peng, Jianhua
Jiang, Yong
Tao, Wei
Li, Cheng
Xie, Huangfan
Deng, Hongkui
Xie, Bingqing https://orcid.org/0009-0002-5929-0332
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (32300675, 32400598, 32288102, 82301658)
Sichuan Science and Technology Program (2022YFS0615, 2025ZNSFSC1019)
Luzhou Science and Technology Program of China (2023SYF136, 2023JYJ019)
Southwest Medical University and Luzhou Government (2021LZXNYD-Z05)
- License Information
-
More Information
Article History
Received: 30 October 2024
Revised: 11 March 2025
Accepted: 24 March 2025
First Online: 6 April 2025
Declarations
:
: The authors declare that there are no competing interests.
: All research using human fibroblasts was approved by the Clinical Research Ethics Committee of China-Japan Friendship Hospital (Ethical approval No: 2009–50) and Stem Cell Research Oversight of Peking University (SCRO201103-03).
: Not applicable.
